Dr. Reddy's Laboratories Limited - stock earnings
RDY Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 165.6 million USD | 866.7 million USD |
2023Q3 | 178.2 million USD | 828.6 million USD |
2023Q2 | 171.1 million USD | 822.0 million USD |
2023Q1 | 116.8 million USD | 766.5 million USD |
2022Q4 | 150.9 million USD | 819.1 million USD |
2022Q3 | 136.5 million USD | 773.5 million USD |
2022Q2 | 150.5 million USD | 660.9 million USD |
2022Q1 | 11.6 million USD | 718.2 million USD |
2021Q4 | 94.8 million USD | 714.1 million USD |
2021Q3 | 133.6 million USD | 776.3 million USD |
2021Q2 | 76.7 million USD | 661.4 million USD |
2021Q1 | 75.6 million USD | 645.9 million USD |
2020Q4 | 2.7 million USD | 674.6 million USD |
2020Q3 | 103.7 million USD | 665.9 million USD |
2020Q2 | 76.7 million USD | 584.7 million USD |
2020Q1 | 101.4 million USD | 588.3 million USD |
2019Q4 | -80.0 million USD | 615.3 million USD |
2019Q3 | 154.9 million USD | 680.9 million USD |
2019Q2 | 96.1 million USD | 557.2 million USD |
2019Q1 | 62.8 million USD | 581.1 million USD |
2018Q4 | 69.4 million USD | 550.9 million USD |
2018Q3 | 69.5 million USD | 523.9 million USD |
2018Q2 | 66.3 million USD | 541.1 million USD |
2018Q1 | 46.5 million USD | 543.5 million USD |
2017Q4 | 52.2 million USD | 594.7 million USD |
2017Q3 | 43.6 million USD | 542.3 million USD |
2017Q2 | 9.2 million USD | 513.5 million USD |
2017Q1 | 48.2 million USD | 548.6 million USD |
2016Q4 | 69.2 million USD | 545.5 million USD |
2016Q3 | 44.2 million USD | 537.2 million USD |
2016Q2 | 18.8 million USD | 480.4 million USD |
2016Q1 | 11.3 million USD | 566.6 million USD |
2015Q4 | 87.2 million USD | 597.7 million USD |
2015Q3 | 109.6 million USD | 605.8 million USD |
2015Q2 | 98.3 million USD | 590.6 million USD |
2015Q1 | 83.1 million USD | 619.9 million USD |
2014Q4 | 90.7 million USD | 606.9 million USD |
2014Q3 | 93.4 million USD | 583.5 million USD |
2014Q2 | 91.7 million USD | 586.2 million USD |
2014Q1 | 80.5 million USD | 581.9 million USD |
2013Q4 | 100.0 million USD | 571.3 million USD |
2013Q3 | 109.7 million USD | 533.7 million USD |
2013Q2 | 94.9 million USD | 555.5 million USD |
2013Q1 | 105.3 million USD | 616.0 million USD |
2012Q4 | 68.9 million USD | 521.6 million USD |
2012Q3 | 76.9 million USD | 544.1 million USD |
2012Q2 | 60.4 million USD | 468.5 million USD |
2012Q1 | 66.8 million USD | 518.4 million USD |
2011Q4 | 96.8 million USD | 522.2 million USD |
2011Q3 | 63.0 million USD | 463.9 million USD |
2011Q2 | 75.0 million USD | 452.3 million USD |
2011Q1 | 75.0 million USD | 452.2 million USD |
2010Q4 | 61.0 million USD | 423.9 million USD |
2010Q3 | 64.2 million USD | 418.4 million USD |
2010Q2 | 35.8 million USD | 353.2 million USD |
2010Q1 | 37.2 million USD | 366.6 million USD |
2009Q4 | -112.4 million USD | 372.7 million USD |
2009Q3 | 45.4 million USD | 384.1 million USD |
2009Q2 | -204.6 million USD | 415.3 million USD |
2009Q1 | -192.4 million USD | 390.7 million USD |
2008Q4 | 50.4 million USD | 379.3 million USD |
2008Q3 | 22.6 million USD | 346.6 million USD |
2008Q2 | 23.9 million USD | 308.5 million USD |
2008Q1 | 25.7 million USD | 331.4 million USD |
2007Q4 | -21.6 million USD | 314.3 million USD |
2007Q3 | 56.7 million USD | 308.2 million USD |
2007Q2 | 80.3 million USD | 384.5 million USD |
2007Q1 | 75.6 million USD | 361.9 million USD |
2006Q4 | 42.9 million USD | 352.0 million USD |
2006Q3 | -5.1 million USD | 153.1 million USD |
2006Q2 | 30.6 million USD | 308.0 million USD |
2006Q1 | -5.2 million USD | 157.2 million USD |
2005Q4 | 14.0 million USD | 131.8 million USD |
2005Q3 | 20.2 million USD | 131.0 million USD |
2005Q2 | -10.6 million USD | 125.3 million USD |
2005Q1 | -10.6 million USD | 124.5 million USD |
2004Q4 | 849623 USD | 99.8 million USD |
2004Q3 | 11.3 million USD | 118.1 million USD |
2004Q2 | 3.6 million USD | 104.6 million USD |
2004Q1 | 3.9 million USD | 110.8 million USD |
2003Q4 | 13.0 million USD | 112.9 million USD |
2003Q3 | 20.4 million USD | 117.8 million USD |
2003Q2 | 14.4 million USD | 91.1 million USD |
2003Q1 | 14.0 million USD | 88.6 million USD |
2002Q4 | 14.5 million USD | 90.9 million USD |
2002Q3 | 19.7 million USD | 101.9 million USD |
2002Q2 | 21.5 million USD | 81.0 million USD |
2002Q1 | 21.4 million USD | 80.8 million USD |
2001Q4 | 27.1 million USD | 94.4 million USD |
2001Q3 | 44.2 million USD | 106.4 million USD |
2001Q2 | 9.4 million USD | 63.9 million USD |
2001Q1 | 340740 USD | 5.5 million USD |
2000Q1 | 317251 USD | 2.6 million USD |
RDY Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 548.6 million USD | 3.0 billion USD |
2022 | 311.3 million USD | 2.8 billion USD |
2021 | 235.5 million USD | 2.6 billion USD |
2020 | 258.8 million USD | 2.3 billion USD |
2019 | 271.9 million USD | 2.2 billion USD |
2018 | 150.8 million USD | 2.2 billion USD |
2017 | 185.8 million USD | 2.2 billion USD |
2016 | 301.9 million USD | 2.3 billion USD |
2015 | 355.2 million USD | 2.4 billion USD |
2014 | 359.6 million USD | 2.2 billion USD |
2013 | 309.4 million USD | 2.1 billion USD |
2012 | 278.1 million USD | 1.9 billion USD |
2011 | 247.5 million USD | 1.7 billion USD |
2010 | 23.8 million USD | 1.6 billion USD |
2009 | -101.7 million USD | 1.4 billion USD |
2008 | 117.3 million USD | 1.3 billion USD |
2007 | 37.9 million USD | 564.5 million USD |
2006 | 291 USD | 438277 USD |
2005 | 4.8 million USD | 445.2 million USD |
2004 | 57.2 million USD | 464.6 million USD |
2003 | 74.0 million USD | 378.3 million USD |
2002 | 100.8 million USD | 340.4 million USD |
2001 | 15.9 million USD | 235.3 million USD |
2000 | 317251 USD | 2.6 million USD |
RDY
Price: 73.51USD
Dividend Yield: 0.67%
Forward Dividend Yield: 1.33%
Payout Ratio: 25.60%
Dividend Per Share: 0.97 USD
Earnings Per Share: 3.77 USD
P/E Ratio: 19.58
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 129000
Ebitda: 142.4 millionMarket Capitalization: 12.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 22
DGR3: 5.95%
DGR5: 5.95%
DGR10: 3.84%